Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

2.
3.

Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.

Narvios AB, Przepiorka D, Tarrand J, Chan KW, Champlin R, Lichtiger B.

Bone Marrow Transplant. 1998 Sep;22(6):575-7.

6.

Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.

Miller WJ, McCullough J, Balfour HH Jr, Haake RJ, Ramsay NK, Goldman A, Bowman R, Kersey J.

Bone Marrow Transplant. 1991 Mar;7(3):227-34.

PMID:
1647829
7.

Prevention of transfusion-transmitted cytomegalovirus infection.

Pamphilon DH, Rider JR, Barbara JA, Williamson LM.

Transfus Med. 1999 Jun;9(2):115-23. Review.

PMID:
10354380
8.

Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study.

Preiksaitis JK, Desai S, Vaudry W, Roberts S, Akabutu J, Grundy P, Wilson B, Boshkov L, Hannon J, Joffres M.

Transfusion. 1997 Sep;37(9):941-6.

PMID:
9308642
12.

[Leukocyte depletion and infection by cytomegalovirus].

Mazeron MC.

Transfus Clin Biol. 2000 Jun;7 Suppl 1:31s-35s. Review. French.

PMID:
10919221
13.

Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.

De Witte T, Schattenberg A, Van Dijk BA, Galama J, Olthuis H, Van der Meer JW, Kunst VA.

Transplantation. 1990 Dec;50(6):964-8.

PMID:
2175059
14.

High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.

Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H.

Transfusion. 2007 Nov;47(11):1972-83.

PMID:
17958525
16.
17.

Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.

Smith D, Lu Q, Yuan S, Goldfinger D, Fernando LP, Ziman A.

Vox Sang. 2010 Jan;98(1):29-36. doi: 10.1111/j.1423-0410.2009.01228.x. Epub 2009 Aug 20.

PMID:
19695013
18.

Transfusion-associated cytomegalovirus infections.

Adler SP.

Rev Infect Dis. 1983 Nov-Dec;5(6):977-93. Review.

PMID:
6318291
19.

Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.

Bass EB, Powe NR, Goodman SN, Graziano SL, Griffiths RI, Kickler TS, Wingard JR.

Bone Marrow Transplant. 1993 Sep;12(3):273-82.

PMID:
8241987
20.

The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors.

Paulin T, Ringdén O, Lönnqvist B, Wahren B, Nilsson B.

Scand J Infect Dis. 1986;18(3):199-209.

PMID:
3016884

Supplemental Content

Support Center